AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 117 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $297,000 | +102.0% | 19,597 | 0.0% | 0.00% | – |
| Q2 2022 | $147,000 | -17.4% | 19,597 | +0.1% | 0.00% | – |
| Q1 2022 | $178,000 | +29.9% | 19,577 | 0.0% | 0.00% | – |
| Q4 2021 | $137,000 | -38.0% | 19,577 | +0.8% | 0.00% | – |
| Q3 2021 | $221,000 | -28.9% | 19,427 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $311,000 | -7.7% | 19,427 | +2.9% | 0.00% | 0.0% |
| Q1 2021 | $337,000 | +13.1% | 18,871 | -14.6% | 0.00% | 0.0% |
| Q4 2020 | $298,000 | +14.6% | 22,091 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $260,000 | -20.2% | 22,091 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $326,000 | +9.4% | 22,091 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $298,000 | -44.2% | 22,091 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $534,000 | +24.8% | 22,091 | -0.7% | 0.00% | 0.0% |
| Q3 2019 | $428,000 | -35.0% | 22,251 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $658,000 | -27.1% | 22,251 | +17.0% | 0.00% | 0.0% |
| Q1 2019 | $903,000 | +31.4% | 19,021 | -0.1% | 0.00% | 0.0% |
| Q4 2018 | $687,000 | -39.3% | 19,031 | +3.6% | 0.00% | -33.3% |
| Q3 2018 | $1,131,000 | -8.9% | 18,371 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,241,000 | +29.0% | 18,371 | +3.6% | 0.00% | 0.0% |
| Q1 2018 | $962,000 | -5.8% | 17,741 | +3.8% | 0.00% | 0.0% |
| Q4 2017 | $1,021,000 | +29.2% | 17,088 | +5.1% | 0.00% | +50.0% |
| Q3 2017 | $790,000 | -7.5% | 16,258 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $854,000 | +15.9% | 16,258 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $737,000 | +19.8% | 16,258 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $615,000 | -31.3% | 16,258 | -31.4% | 0.00% | -33.3% |
| Q3 2016 | $895,000 | +106.7% | 23,708 | -3.5% | 0.00% | +200.0% |
| Q2 2016 | $433,000 | +51.4% | 24,578 | +4.3% | 0.00% | 0.0% |
| Q1 2016 | $286,000 | -52.1% | 23,559 | -4.0% | 0.00% | -50.0% |
| Q4 2015 | $597,000 | -8.7% | 24,529 | -33.5% | 0.00% | -33.3% |
| Q3 2015 | $654,000 | +0.5% | 36,859 | 0.0% | 0.00% | +50.0% |
| Q2 2015 | $651,000 | – | 36,859 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |